• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19.

作者信息

Chewcharat Api, Chang Yuan-Ting, Sise Meghan E, Bhattacharyya Roby P, Murray Megan B, Nigwekar Sagar U

机构信息

Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts, USA.

Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.

出版信息

Kidney Int Rep. 2021 Jan;6(1):196-199. doi: 10.1016/j.ekir.2020.10.010. Epub 2020 Oct 21.

DOI:10.1016/j.ekir.2020.10.010
PMID:33106779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7577277/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a319/7785408/63fc447d3b24/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a319/7785408/63fc447d3b24/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a319/7785408/63fc447d3b24/gr1.jpg

相似文献

1
Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19.关于排除新冠肺炎肾病患者参与的3期随机对照试验
Kidney Int Rep. 2021 Jan;6(1):196-199. doi: 10.1016/j.ekir.2020.10.010. Epub 2020 Oct 21.
2
A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".一项评估使用 gammaCore®-Sapphire 设备进行迷走神经刺激治疗中度至重度 CoViD-19 呼吸症状的前瞻性、随机、对照研究（SAVIOR）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 26;21(1):576. doi: 10.1186/s13063-020-04486-w.
3
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.在新冠疫情期间使用卡介苗增强医护人员的非特异性防护：丹麦一项随机对照试验研究方案的结构化总结
Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.
4
Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.在一项大型 2 型糖尿病二肽基肽酶 4 抑制剂利拉利汀临床试验计划的个体患者水平数据分析的汇总分析中，肾脏疾病终点。
Am J Kidney Dis. 2015 Sep;66(3):441-9. doi: 10.1053/j.ajkd.2015.03.024. Epub 2015 May 7.

引用本文的文献

1
Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19.奈玛特韦-利托那韦在晚期肾功能不全合并 COVID-19 患者中的安全性和有效性
Am J Kidney Dis. 2025 Apr 7. doi: 10.1053/j.ajkd.2025.02.603.
2
Molecular Phenotyping of Patients with Sepsis and Kidney Injury and Differential Response to Fluid Resuscitation.脓毒症合并肾损伤患者的分子表型分析及对液体复苏的不同反应
Res Sq. 2024 Jul 2:rs.3.rs-4523416. doi: 10.21203/rs.3.rs-4523416/v1.
3
Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.

本文引用的文献

1
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.瑞德西韦用于急性或慢性肾脏病合并新型冠状病毒肺炎患者的研究
J Am Soc Nephrol. 2020 Jul;31(7):1384-1386. doi: 10.1681/ASN.2020050589. Epub 2020 Jun 8.
2
Acute kidney injury in patients hospitalized with COVID-19.COVID-19 住院患者中的急性肾损伤。
Kidney Int. 2020 Jul;98(1):209-218. doi: 10.1016/j.kint.2020.05.006. Epub 2020 May 16.
3
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology.新型冠状病毒肺炎相关急性肾损伤：独特病理生理学的新证据
瑞德西韦对 COVID-19 合并肾功能受损住院患者不良肾脏结局的影响。
PLoS One. 2023 Feb 27;18(2):e0279765. doi: 10.1371/journal.pone.0279765. eCollection 2023.
4
A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.瑞德西韦治疗 COVID-19 合并严重肾脏疾病患者的倾向评分匹配观察性研究。
Kidney360. 2021 Dec 3;3(2):269-278. doi: 10.34067/KID.0006152021. eCollection 2022 Feb 24.
5
COVID-19 Survival and its impact on chronic kidney disease.COVID-19 患者的生存情况及其对慢性肾脏病的影响。
Transl Res. 2022 Mar;241:70-82. doi: 10.1016/j.trsl.2021.11.003. Epub 2021 Nov 10.
6
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis.终末期肾病患者接种 SARS-CoV-2 疫苗后的免疫原性率：系统评价和荟萃分析。
JAMA Netw Open. 2021 Oct 1;4(10):e2131749. doi: 10.1001/jamanetworkopen.2021.31749.
7
Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis.肾移植受者中的2019冠状病毒病：一项系统综述和荟萃分析。
Singapore Med J. 2023 Oct;64(10):593-602. doi: 10.11622/smedj.2021171.
J Am Soc Nephrol. 2020 Jul;31(7):1380-1383. doi: 10.1681/ASN.2020040419. Epub 2020 May 4.
4
Coronavirus disease 2019 (COVID-19): A literature review.新型冠状病毒病 2019（COVID-19）：文献综述。
J Infect Public Health. 2020 May;13(5):667-673. doi: 10.1016/j.jiph.2020.03.019. Epub 2020 Apr 8.
5
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.慢性肾脏病与2019冠状病毒病（COVID-19）严重感染相关。
Int Urol Nephrol. 2020 Jun;52(6):1193-1194. doi: 10.1007/s11255-020-02451-9. Epub 2020 Mar 28.
6
COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?新冠病毒与透析单位：我们目前了解到了什么以及我们应该怎么做？
Am J Kidney Dis. 2020 Jul;76(1):1-3. doi: 10.1053/j.ajkd.2020.03.008. Epub 2020 Mar 23.
7
Update on the Burden of CKD.慢性肾脏病负担最新情况
J Am Soc Nephrol. 2017 Apr;28(4):1020-1022. doi: 10.1681/ASN.2016121374. Epub 2017 Mar 16.